Manuel Aivado - Mar 30, 2022 Form 4/A - Amendment Insider Report for AILERON THERAPEUTICS INC (ALRN)

Role
President and Chief Executive Officer, Director
Signature
/s/ Richard Wanstall, attorney in fact for Manuel Aivado
Stock symbol
ALRN
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/30/2022, 08:33 PM
Date Of Original Report
Mar 24, 2022
Previous filing
Mar 24, 2022
Next filing
Aug 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +1.13M $0.00 1.13M Mar 30, 2022 Common Stock 1.13M $0.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022.
F2 The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026.

Remarks:

President and Chief Executive Officer